Bharat Biotech, the Hyderabad-based pharmaceutical firm that has been developing coronavirus vaccine Covaxin, today said that it had applied to the central drug regulator seeking emergency use authorisation.
It is the third firm after Serum Institute of India and American pharma giant Pfizer to apply for emergency use approval.
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and is currently in Phase 3 trials. The trials are on at 18 sites across the country with over 22,000 volunteers.
India recorded 32,981 new COVID-19 cases in the last 24 hours, taking the total number of active coronavirus cases in the country to 3,96,729, said the Union Ministry of Health and Family Welfare on Monday. With 39,109 new recoveries, the number of overall recovered COVID-19 patients stand at 91,39,901, pushing the recovery rate to 94.45 per cent today.
The overall COVID-19 cases reached 96,77,203, including 3,96,729 active cases and 91,39,901 recoveries. With 391 new deaths, the casualties mounted to 1,40,573.
Here are the LIVE updates on India Coronavirus Cases:
American pharmaceutical firm Pfizer, which has asked the DCGI (Drugs Controller General of India) for emergency approval of its coronavirus vaccine, has said it is prepared to address a key challenge in the distribution of its vaccine - ultra-cold storage.
The US firm, which has developed Covid vaccine jointly with German partner BioNTech has sought India's approval as the United Kingdom and Bahrain prepare for the vaccine rollout.
The vaccine, however, needs to be stored and transported at - 70 degrees Celsius. Experts in India have raised concern about the logistics as most vaccines in the country are stored between 2 and 8 degrees. Read
Resident doctors across Karnataka are holding a symbolic protest to remind the government of what they say are deficiencies in the medical education department. The doctors claim that the government is using their services for Covid-related work due to which their has been no proper clinical academic activities in their post-graduate courses for which they are still being charged fees in lakhs. Read
The death toll rose to 370 after a patient died due to the infection, he said.
On Sunday, 69 people were discharged from GB Pant Hospital, the main referral facility for COVID-19 patients in the state.
Tripura currently has 417 active coronavirus cases, while 32,087 people have recovered from the disease.
In the last 24 hours, 43,006 samples were tested in Andhra Pradesh, out of which 316 were detected COVID-19 positive. At present, there are 5,626 are active cases in the state, Andhra Pradesh state Covid nodal officer said.
With 595 new recoveries, the total number of recovered cases has climbed to 8,59,624.
In the past 24 hours, five deaths have been reported.
Speaking at the India-Portugal Tech Summit, organised by the Department of Science and Technology and the Confederation of Indian Industry (CII), Mr Vardhan said the government has announced a $120 million grant for COVID-19 vaccine research.
This is being provided for COVID Suraksha Mission and is to be used purely for research and development in this field, he said.
Delhi reports 1,674 new #COVID19 cases, 3,818 recoveries and 63 deaths today.
- ANI (@ANI) December 7, 2020
Total cases 5,93,924
Total recoveries 5,61,732
Death toll 9,706
Active cases 22,486 pic.twitter.com/7NVZo15riL
Coronavirus Fact vs Myths | Can small children pass on #COVID19 even if they are not showing symptoms?
- NDTV (@ndtv) December 7, 2020
Dr Uma Kumar, Professor and HoD, Department of Rheumatology, AIIMS answers pic.twitter.com/lhKqgBveSM
After Pfizer, Serum Institute Seeks Approval For Covid-19 Vaccine: Sources
- NDTV (@ndtv) December 7, 2020
NDTV's Sukirti Dwivedi reports pic.twitter.com/ucYm2GQ2oa
"We need to wait, because these vaccines are only going to compliment our efforts today, but not replace hand sanitisation and other COVID-19 protocols.. so we need to be patient and continue taking precautions," says Dr Rajeev Seth, senior pediatrician on #COVID19 vaccine pic.twitter.com/356ECguuh0
- NDTV (@ndtv) December 7, 2020
China's Sinovac Biotech has secured $515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday, as it expects efficacy data of its experimental shot this month. Read more
Donald Trump's personal lawyer Rudy Giuliani has tested positive for Covid-19, the president said Sunday, the latest member of his inner circle to contract the disease.
It was unclear whether Giuliani was experiencing symptoms, but at age 76 the former New York mayor is considered part of a high-risk group.
He has been seen frequently without a mask -- CNN showed film of him Thursday in Atlanta walking maskless down a hall chatting with several other people whose faces were uncovered -- and other members of his legal team presumably have been exposed. Read